Revenue remained stable at €3.7bn despite Middle East disruptions, but recurring EBITDA dropped to €212m. Record order intake boosted backlog to €25bn, while strong liquidity and capital returns supported shareholder value.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.